Deer X & Co. L.P. 4
4 · Hinge Health, Inc. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Bessemer Venture Partners X L.P.
10% Owner
Transactions
- Conversion
Class A Common Stock
2025-11-18+4,108,707→ 4,108,707 total(indirect: See footnote) - Sale
Class A Common Stock
2025-11-18$40.05/sh−725,000$29,036,250→ 3,383,707 total(indirect: See footnote) - Conversion
Class B Common Stock
2025-11-18−4,108,707→ 0 total(indirect: See footnote)→ Class A Common Stock (4,108,707 underlying)
Footnotes (4)
- [F1]On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.
- [F2]BVP X sold 373,955 shares of Class A Common Stock of the Issuer, and BVP X Inst. sold 351,045 shares of Class A Common Stock of the Issuer.
- [F3]Deer X & Co. Ltd. is the general partner of Deer X & Co. L.P., which is the general partner of each of Bessemer Venture Partners X L.P. ("Bessemer X") and Bessemer Venture Partners X Institutional L.P. ("Bessemer X International," and together with Bessemer X, the "Bessemer Entities"). As a result, each of Deer X & Co. Ltd. and Deer X & Co. L.P. may be deemed to share beneficial ownership of the securities held by the Bessemer Entities.
- [F4]Consists of (i) 1,745,316 shares held by BVP X and (ii) 1,638,391 shares held by BVP X Inst.